QuantiFERON–CMV is not available in the United States.
QuantiFERON–CMV is CE marked for commercial use in Europe

Search Results: Displaying all items (49)

First Author Title Journal Publication Date
Cantisán S. Impact of age and cytomegalovirus on CD8(+) T-cell compartment remodeling after solid organ transplantation: A one-year follow-up study. Experimental gerontology 2017
Yong MK. Identifying Cytomegalovirus (CMV) complications using the Quantiferon-CMV assay after Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of infectious diseases 2017
Banas B. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients. BMC immunology 2017
Sood S. Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients. World journal of hepatology 2016
Picat MQ. Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients. PloS one 2017
Yong MK. Quantifying Adaptive and Innate Immune Responses in HIV-Infected Participants Using a Novel High Throughput Assay. PloS one 2016
Lee SM. Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Annals of laboratory medicine 2017
Tarasewicz A. Clinical Utility of QuantiFERON-Cytomegalovirus Test in Management of Kidney Transplant Recipients. Transplantation proceedings 2016
Cantisán S. Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients. Antiviral research 2016
Forner G. CMV-ELISPOT but not CMV-QuantiFERON assay is a novel biomarker to determine the risk of congenital CMV infection in pregnant women. Journal of clinical microbiology 2016
Bono P. Quantiferon CMV assay in allogenic stem cell transplant patients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016
Eldar-Yedidia Y. Low Interferon Relative-Response to Cytomegalovirus Is Associated with Low Likelihood of Intrauterine Transmission of the Virus. PloS one 2016
Castón JJ. Interferon-γ production by CMV-specific CD8+ T lymphocytes provides protection against cytomegalovirus reactivation in critically ill patients. Intensive care medicine 2016
Herling M. Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2016
Saldan A. Comparison of cell-mediated immune assays CMV-ELISPOT and CMV-QuantiFERON in CMV seropositive and seronegative pregnant and non-pregnant women. Journal of clinical microbiology 2016
Kotton CN. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013
Fernández-Ruiz M. Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation. Clinical & translational immunology 2014
Calarota SA. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2014
Abate D. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants. Journal of virological methods 2014
Melendez D. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime? Expert review of clinical immunology 2014
Load More Results